Study from 2022 suggests that taking it for any sustained period leads to a reduction of overall body weight.Other experiments present enhanced weight loss among patients combining SGLT2 inhibitors with other drugs, like metformin or GLP-1 receptor agonists.Semaglutide is really a GLP-one agonist. It imitates an intestinal hormone that stimulates i